Cardiovascular disease and its risk factors in IDDM in Europe

Diabetes Care

Volumn 19, Issue 7, 1996, Pages 689-697

  Koivisto, V A ^a,b,c   Stevens, L K ^a,b,c   Mattock, M ^a,b,c   Ebeling, P ^a,b,c   Muggeo, M ^a,b,c   Stephenson, J ^a,b,c   Idzior Walus, B ^a,b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Department of Epidemiology and Public Health ^*  (Finland)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DIABETIC RETINOPATHY; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEINURIA; SMOKING; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029951345     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.7.689     Document Type: Article

References (50)

1. Rubin JR, Altman WM, Mendelson DN: Health care expenditure for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78:809A-809F, 1994
2. Pyörälä K, Laakso M, Uusitupa MDiabetes and athlerosclerosis:an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
3. Maser RE, Wolfson SK Jr, Ellis D, Stein EA, Drash AL, Becker DJ, Dorman JS, Orchard TJ:Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus:interrelations and risk factor profiles. Arteriosder Thromb 11:958-965, 1991
4. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H:A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I:causes and death rates. Diabctologia 33:538-541, 1990
5. Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H:Risk factors for macrovascular disease in diabetes mellitus:the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabctologia 34:590-594, 1991
6. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR:Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
7. Donahue RP, Orchard TJ:Diabetes mellitus and macrovascular complications:an epidemiological perspective. Diabetes Care 15:1141-1155, 1992
8. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group:Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434-444, 1993
9. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH:Prevalence of complications in IDDM by sex and duration:Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
10. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK, Drash AL:Factors associated with avoidance of severe complications after 25 yr of IDDM:Pittsburgh Epidemiology of Diabetes Complications Study I. Diabe-tes Care 13:741-747, 1990
11. Head J, Fuller JH:International variations in mortality among diabetic patients:the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33:477-481, 1990
12. The EURODIAB 1DDM Complications Study Group:Microvascular and acute complications in insulin dependent diabetes mellitus:the EURODIAB Complications Study. Diabctologia 37:278-285, 1994
13. Rose GA, Blackhorn H, Gilum RF, Prineas RJ:Cardiovascular Survey Methods. 2nd ed. Geneva, World Health Org., 1982 (monogr. no. 56)
14. Bucolo G, David H:Quantitative determination of serum triglycérides by the use of enzymes. Clin Chem 19:476-482, 1973
15. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW:Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
16. Warnick GR, Albers JJ:A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76, 1978
17. Friedewald WT, Levy Rl, Fredrickson DS:Estimation of the concentration of lowdensity lipoprotein in cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Cliem 18:499-502, 1972
18. lc. Clin Chem 39:663-666, 1993
19. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN:Simple immunoturbidometric method for determining urinary albumin at low concentrations using centrifugal analyzer. J Clin Path 40:465-468, 1987
20. Diabetes Epidemiology Research International Mortality Study Group:International evaluation of cause-specific mortality in IDDM. Diabetes Care 14:55-60, 1991
21. Marks HH, Krall LP:Onset, course, prognosis, and mortality in diabetes mellitus. In Joslin's Diabetes Mellitus. Marble A, White P, Bradley KF, Krall LP, Eds. Philadelphia, Lea and Feabiger, 1971, p. 209-254
22. Karlefors T:Circulatory studies during exercise with particular reference to diabetics. Acta Med Scand 180 (Suppl. 449):1-87, 1966
23. Borch-Johnsen K, Nissen H, Sailing N, Henriksen E, Kreiner S, Decken T, Nerup J:The natural history of insulin-dependent diabetes in Denmark. II. Long-term survival:who and why. Diabetic Med 4:211-216,1987
24. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Decken T:Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy:incidence and risk factors. Diabetologia 30:144-148, 1987
25. Koistinen MJ:Prevalence of asymptomatic myocardial ischemia in diabetic subjects. Br Med j 301:92-95, 1990
26. Orchard TJ:From diagnosis and classification to complications and therapy. Diabetes Care 17:326-338, 1994
27. Orchard TJ, Drash A:Does glycosylated hemoglobin predict the incidence of late complications of 1DDM. Diabetes 43 (Suppl. 1):25A, 1994
28. Diabetes Control and Complications Trial Research Group:The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
29. Borch-Johnsen K, Kreiner S:Proteinuria:value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Er Med] 294:1651-1654, 1987
30. Winocour PH, Durington PN, Ishola M, Anderson DC, Cohen H:Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Er Med J 294:1648-1651, 1987
31. Decken T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A:Albuminuria reflects widespread vascular damage:the Steno hypothesis. Diabetologia 32:219-226, 1989
32. Dullaart RFP, Dikkeschei LD, Doorenbos H:Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 32:685-689, 1989
33. Jay RH, Jones SL, Hill CE, Richmond W, Viberti GC, Rampling MW, Betteridge DJ:Blood rheology and cardiovascular risk factors in type 1 diabetes:relationship with microalbuminuria. Diabetic Med 8:662-667, 1991
34. West KM, Ahuja MMS, Bennett PH, Czyzyk A, DeAcosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krolewski AS, Miki E, Schliack V, Teuscher A, Watkins PJ, Stober JA:The role of circulating glucose and triglycéride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:361-369, 1983
35. Reckless JPD, Betteridge DJ, Wu P, Payne B, Galton DJ:High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med ] 1:883-886, 1978
36. Beach KW, Brunzell JD, Conquest LL, Strandness DG:The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetes. Diabetes 28:836-840,1979
37. Laakso M, Sarlund H, Mykk-anen L:Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
38. Taskinen M-R:Hyperlipidemia in diabetes. Bailliere's Clin Endocrine! Metab 4:743-775, 1990
39. Earle K, Walker J, Hill C, Viberti GC:Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677,1992
40. Rosenstock J, Strowig S, Gereone S, Raskin P:Reduction in cardiovascular risk factors with intensive diabetes treatment in insulin-dependent diabetes mellitus. Diabetes Care 10:729-734, 1987
41. Kannel WB, McGee DL:Diabetes and cardiovascular risk factors:the Framingham Study. Circulation 59:8-13, 1979
42. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H:Mortality from coronary heart disease and stroke in relation to degree of glycaemia:the Whitehall Study. Br Med J 287:867-870, 1983
43. Koivisto VA, DeFronzo RA:Physical training and insulin sensitivity. Diabetes Metab Rev 1:445-481,1986
44. Kelemen MH, Effron MB, Valenti SA, Stewart KJ:Exercise training combined with antihypertensive drug therapy:effects on blood lipids, blood pressure, and left ventricular mass. JAMA 263:2766-2771, 1990
45. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS:Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men:the Lipid Research Clinics Mortality Follow-Up Study. N Engl J Mecî 319:1379-1384, 1988
46. Salonen JT, Slater JS, Tuomilehto J, Raurama R:Leisure time and occupational physical activity:risk of death from ischémie heart disease. Am J Epidemiol 127:87-94, 1988
47. Chazan Bl, Balodimos MC, Ryan JR, Marble A:Twenty-five to forty-five years of diabetes with and without vascular complications. Diabetologia 6:565-569, 1970
48. Reaven GM:Role of insulin resistance in human disease:Banting lecture 1988. Diabetes 37:1595-1607, 1988
49. Björntorp P:Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143,1991
50. Ebeling P, Koivisto VA:Physiological importance of dehydroepiandrosterone. Lancet 343:1479-1481, 1994